unknown
Stage
2016
Founded
2
Investors
About
Atriva Therapeutics is a clinical-stage biopharmaceutical company developing host-targeting inhibitors against respiratory viral infections.
Explore Atriva Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.